PTHS
Price
$25.94
Change
+$0.84 (+3.35%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
77.48M
41 days until earnings call
Intraday BUY SELL Signals
RIGL
Price
$37.80
Change
-$1.32 (-3.37%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
710.08M
Intraday BUY SELL Signals
Interact to see
Advertisement

PTHS vs RIGL

Header iconPTHS vs RIGL Comparison
Open Charts PTHS vs RIGLBanner chart's image
Pelthos Therapeutics
Price$25.94
Change+$0.84 (+3.35%)
Volume$200
Capitalization77.48M
Rigel Pharmaceuticals
Price$37.80
Change-$1.32 (-3.37%)
Volume$12.04K
Capitalization710.08M
PTHS vs RIGL Comparison Chart in %
PTHS
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PTHS vs. RIGL commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTHS is a Hold and RIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PTHS: $25.10 vs. RIGL: $39.12)
Brand notoriety: PTHS and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTHS: 25% vs. RIGL: 60%
Market capitalization -- PTHS: $77.48M vs. RIGL: $710.08M
PTHS [@Biotechnology] is valued at $77.48M. RIGL’s [@Biotechnology] market capitalization is $710.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTHS’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 1 green FA rating(s).

  • PTHS’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, RIGL is a better buy in the long-term than PTHS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTHS’s TA Score shows that 2 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • PTHS’s TA Score: 2 bullish, 7 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than PTHS.

Price Growth

PTHS (@Biotechnology) experienced а -10.36% price change this week, while RIGL (@Biotechnology) price change was -16.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

PTHS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($710M) has a higher market cap than PTHS($77.5M). RIGL YTD gains are higher at: -8.662 vs. PTHS (-19.032). RIGL has higher annual earnings (EBITDA): 124M vs. PTHS (-22.24M). RIGL has more cash in the bank: 137M vs. PTHS (14.2M). PTHS has less debt than RIGL: PTHS (3.48M) vs RIGL (60.9M). RIGL has higher revenues than PTHS: RIGL (282M) vs PTHS (7.41M).
PTHSRIGLPTHS / RIGL
Capitalization77.5M710M11%
EBITDA-22.24M124M-18%
Gain YTD-19.032-8.662220%
P/E RatioN/A6.32-
Revenue7.41M282M3%
Total Cash14.2M137M10%
Total Debt3.48M60.9M6%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
10
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTHSRIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
PTHS
Daily Signal:
Gain/Loss:
RIGL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBBHF0.06N/A
+3.16%
Cobalt Blue Hldgs.
HSEEF0.08N/A
N/A
Hill Incorporated
KRYAF91.42N/A
N/A
Kerry Group plc
APMSF30.50N/A
N/A
Aperam S.A.
JAPPF14.48N/A
N/A
Japan Systems Techniques Co. Ltd.

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been loosely correlated with KLRS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PTHS jumps, then KLRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-0.46%
KLRS - PTHS
43%
Loosely correlated
N/A
LIXT - PTHS
34%
Loosely correlated
+7.04%
MBIO - PTHS
29%
Poorly correlated
-0.92%
PASG - PTHS
28%
Poorly correlated
+6.24%
RIGL - PTHS
25%
Poorly correlated
+3.06%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with FTRE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then FTRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+3.06%
FTRE - RIGL
33%
Loosely correlated
-3.45%
SNDX - RIGL
33%
Loosely correlated
+4.74%
AKBA - RIGL
33%
Loosely correlated
N/A
AGIO - RIGL
33%
Poorly correlated
+3.35%
VCYT - RIGL
32%
Poorly correlated
-1.39%
More